A Short Review on the Impact of Artificial Intelligence in Diagnosis Diseases: Role of Radiomics In Neuro-Oncology: Impact of AI in Neuro-Oncology Diseases

  • Rahimi M
  • Rahimi P
N/ACitations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Artificial Intelligence (AI) is rapidly transforming various aspects of healthcare, including the field of diagnostics and treatment of diseases. This review article aimed to provide an in-depth analysis of the impact of AI, especially, radiomics in the diagnosis of neuro-oncology diseases. Indeed, it is a multidimensional task that requires the integration of clinical assessment, neuroimaging techniques, and emerging technologies like AI and radiomics. The advancements in these fields have the potential to revolutionize the accuracy, efficiency, and personalized approach to diagnosing neuro-oncology diseases, leading to improved patient outcomes and enhanced overall neurologic care. However, AI has some limitations, and ethical challenges should be addressed via future research.

Cite

CITATION STYLE

APA

Rahimi, M., & Rahimi, P. (2023). A Short Review on the Impact of Artificial Intelligence in Diagnosis Diseases: Role of Radiomics In Neuro-Oncology: Impact of AI in Neuro-Oncology Diseases. Galen Medical Journal, 12. https://doi.org/10.31661/gmj.v12i.3158

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free